Seismic Therapeutic reels in $101m Series A

Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has secured $101 million in Series A funding.

Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has secured $101 million in Series A funding. Lightspeed Venture Partners led the round.

Source: Press Release